
Duoning Biotech
Duoning Biotech is a serum-free medium and technology developer based on international animal cell culture concepts.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | Series C | ||
Total Funding | 000k |
Related Content
Duoning Bio is a leading provider of bioprocess solutions tailored for the biopharmaceutical industry. The company specializes in offering a comprehensive range of products and services that enhance production efficiency and ensure high product quality. Duoning Bio serves clients in the biopharmaceutical sector, including manufacturers of vaccines, monoclonal antibodies, and other biologics. Operating primarily in the bioprocessing market, the company leverages its expertise to deliver customized solutions that meet the stringent regulatory requirements of the industry.
The business model of Duoning Bio revolves around the sale of bioprocessing equipment, consumables, and technical services. Revenue is generated through direct sales of these products and services, as well as through long-term service contracts with biopharmaceutical companies. The company’s offerings include single-use systems, cell culture media, and downstream processing solutions, all designed to streamline the biomanufacturing process.
Duoning Bio differentiates itself through its commitment to innovation and quality, continually investing in research and development to stay ahead of industry trends. The company’s technical services team provides expert support to clients, ensuring optimal performance of their bioprocessing operations.
Keywords: bioprocessing, biopharmaceutical, vaccines, monoclonal antibodies, single-use systems, cell culture media, downstream processing, regulatory compliance, technical services, innovation.
Tech stack
Investments by Duoning Biotech
Edit